ImportRefusal LogoImportRefusal

Glaxo Smith Kline Consumer Health Care

✅ Low Risk

FEI: 3004889186 • Buehl/Baden • GERMANY

FEI

FEI Number

3004889186

📍

Location

Buehl/Baden

🇩🇪

Country

GERMANY
🏢

Address

Gmbh & Co. Kg, , Buehl/Baden, , Germany

Low Risk

FDA Import Risk Assessment

20.3
LowModerateHighCritical

This firm has a minimal history of FDA import refusals with low-severity violations.

Statistics

1
Total Refusals
2
Unique Violations
10/23/2007
Latest Refusal
10/23/2007
Earliest Refusal

Score Breakdown

Violation Severity
40.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

Refusal History

DateProductViolationsDivision
10/23/2007
63R06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
472NO ENGLISH
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Glaxo Smith Kline Consumer Health Care's FDA import refusal history?

Glaxo Smith Kline Consumer Health Care (FEI: 3004889186) has 1 FDA import refusal record(s) in our database, spanning from 10/23/2007 to 10/23/2007.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxo Smith Kline Consumer Health Care's FEI number is 3004889186.

What types of violations has Glaxo Smith Kline Consumer Health Care received?

Glaxo Smith Kline Consumer Health Care has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Glaxo Smith Kline Consumer Health Care come from?

All FDA import refusal data for Glaxo Smith Kline Consumer Health Care is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.